2025.08.22 由于报告期间内出售与辉同行，若剔除与辉同行所产生的一次性开支及溢利，经调整净溢利由1.042亿 元同比增加30%至1.354亿元。 董宇辉的出走在业务层面也产生了影响。财报显示，该财年，东方甄选GMV由上个财年的143亿元同比 降低39.2%至87亿元。GMV降低带动自营产品存货成本与物流成本降低，使该财年总营收成本同比减少 38.2%至30亿元，同时毛利也从17亿元同比减少17%至14亿元。得益于自营产品与直播电商业务健康开 展，毛利率由25.9%提升至32%。 值得注意的是，此前支付给董宇辉的1.4亿元体现在本财年财报行政开支部分。财报显示，东方甄选 2025财年持续经营业务的行政开支由2024财年的3.956亿元增加22.5%至4.848亿元，主要由于公司在 2024年7月25日分派与辉同行所有剩余未分派溢利所致。 此前在东方甄选股东沟通会上，东方甄选行政总裁俞敏洪表示，董宇辉离职可以得到与辉同行净利润的 50%。分配后，与辉同行账面仍剩1.41亿元。彼时俞敏洪表示，剩下的1.41亿元也将分配给董宇辉，并 将在财年报告中体现出来。 本文字数：1303，阅读时长大约2分钟 作者 |第 ...

Group 1 - The Ministry of Industry and Information Technology and the National Health Commission of China have launched a notice to collect innovative applications of biological manufacturing technologies in the food processing sector, focusing on areas such as food raw materials, food additives, and food and beverage manufacturing [1] - The application directions should align with the goal of building a diversified food supply system and have significant promotional value for industry development, referencing safety evaluation requirements for genetically modified microorganisms [1] - Specific conditions for the applications include: products must be developed domestically and have entered small-scale trial production or mass production; products must have sufficient research results proving their safety or have been approved in other countries for food processing; and products must meet the criteria for "three new foods" in China but have not yet been approved [1] Group 2 - Huazhong Securities has released a research report indicating that frontier research in life sciences remains active, with a global biotechnology revolution accelerating its integration into economic and social development, providing new solutions for major challenges such as health, climate change, resource security, and food security [2] - The report suggests that the biological economy is emerging as a trillion-dollar sector, highlighting the potential for significant investment opportunities in this field [2]